Evidence map›Paper›PMID 31900737›Full record

SynthesisNeurosurgical review2021

Complications after frame-based stereotactic brain biopsy: a systematic review.

Maximilien Riche, Aymeric Amelot, Matthieu Peyre, Laurent Capelle, Alexandre Carpentier, Bertrand Mathon

Registry-linked trialAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Neurosurgical review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05318612 (), which is not on this map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05318612 phase3active not recruitingnot on this mapstarted 2022, after this paper: background citation

(Cost)Effectiveness of MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma: a Prospective Multicenter Randomized Controlled Trial (EMITT)

TypeinterventionalSponsorRadboud University Medical CenterRan2022 to 2027Enrolled238ConditionsPrimary GlioblastomaArmsLaser Interstitial Thermal Therapy (LITT), Biopsy
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 146 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Fluorescence-aided stereotactic needle biopsies for brain tumors: experience on 516 cases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maximilien RicheDepartment of Neurosurgery, AP-HP, GHU La Pitié-Salpêtrière - Charles Foix, F-75013, Paris, France.
Aymeric AmelotDepartment of Neurosurgery, AP-HP, GHU La Pitié-Salpêtrière - Charles Foix, F-75013, Paris, France.
Matthieu PeyreDepartment of Neurosurgery, AP-HP, GHU La Pitié-Salpêtrière - Charles Foix, F-75013, Paris, France.
Laurent CapelleDepartment of Neurosurgery, AP-HP, GHU La Pitié-Salpêtrière - Charles Foix, F-75013, Paris, France.
Alexandre CarpentierDepartment of Neurosurgery, AP-HP, GHU La Pitié-Salpêtrière - Charles Foix, F-75013, Paris, France.
Bertrand MathonDepartment of Neurosurgery, AP-HP, GHU La Pitié-Salpêtrière - Charles Foix, F-75013, Paris, France. bertrand.mathon@aphp.fr.ORCID https://orcid.org/0000-0002-9182-5846
Sorbonne Université · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stereotactic frame-based brain biopsy is one of the most used procedures to obtain brain tissue. This procedure is usually considered as mini-invasive, quick, efficient, and safe even if results of the different studies are widely heterogenous. The objective of this review of the literature is to describe and analyze the complications of stereotactic frame-based brain biopsy. About 132 articles were found after a research in the Medline database. We only considered English references published between 1994 and June 2019. Additional studies were found by using the references from articles identified in the original search. This systematic review was conducted according to PRISMA guidelines. After applying exclusion criteria, we eventually considered 25 relevant studies. The mortality rate varies from 0.7 to 4%. Overall morbidity ranges from 3 to 13%. Most of the complications are revealed by the following symptoms: neurological impairment (transient or permanent), seizure, and unconsciousness. Symptomatic hemorrhage range varies from 0.9 to 8.6%, whereas considering asymptomatic bleeding, the range may be up to 59.8%. Complications were clinically evident within minutes to a few hours after the biopsy. Corrective surgeries are very rare (< 1%). Complications occurring after a frame-based stereotactic brain biopsy are rare but with serious side effects. It rarely leads to death or to permanent neurological impairment. Description and classification of complications are often heterogeneous in the literature. The use of a grading scale could help comparisons between series from around the world. Future studies should establish a score that allows neurosurgeon to predict post-biopsy complications.

Indexed as

BiopsyBrainBrain NeoplasmsCerebral HemorrhageFemaleHumansMalePostoperative ComplicationsStereotaxic TechniquesAdverse eventBrain tumorIntracranial hemorrhageNeedle biopsyNeurosurgeryStereotaxy

Identifiers

PMID31900737
OpenAlexW2997413954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.